Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Delcath Systems Inc DCTH

Healthcare Medical Devices Diagnostics & Research
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT) percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while... see more

Recent & Breaking News (NDAQ:DCTH)

StockNewsNow.com Publishes New SNNLive Video Interview With Delcath Systems, Inc.

Marketwired October 9, 2015

Delcath Announces National Reimbursement Coverage For CHEMOSAT Procedures In Germany

PR Newswire October 8, 2015

Delcath Systems Appoints CEO Jennifer Simpson To Board Of Directors

PR Newswire October 6, 2015

Data Supporting Delcath's Chemosat System Presented At The Cardiovascular and Interventional Radiology Society Annual Meeting

PR Newswire September 30, 2015

Retrospective Study Examining Delcath's CHEMOSAT And Isolated Hepatic Perfusion Presented At ECCO Annual Meeting

PR Newswire September 28, 2015

Delcath Announces Acceptance Of Abstract For Presentation At RSNA Annual Meeting

PR Newswire September 9, 2015

Delcath To Present At The 17th Annual Rodman & Renshaw Conference

PR Newswire September 2, 2015

Delcath Reports 2015 Second Quarter Financial Results

PR Newswire August 5, 2015

Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress

PR Newswire August 4, 2015

Delcath Receives Orphan Drug Designation From FDA For Melphalan To Treat Cholangiocarcinoma

PR Newswire July 20, 2015

Delcath Announces Pricing Of Public Offering

PR Newswire July 16, 2015

Delcath Announces Acceptance Of Abstracts For Presentation At The Cardiovascular And Interventional Radiology Society Annual Meeting

PR Newswire June 9, 2015

Delcath to Webcast Management's Presentation at Annual Meeting of Shareholders on June 10, 2015

PR Newswire June 5, 2015

Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015

PR Newswire May 29, 2015

Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients

PR Newswire May 27, 2015

Delcath Names Dr. Jennifer Simpson President And CEO

PR Newswire May 26, 2015

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment

PR Newswire May 21, 2015

Delcath Reports 2015 First Quarter Financial Results

PR Newswire May 6, 2015

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma

PR Newswire April 21, 2015

Delcath to present at Needham & Company's 14th Annual Healthcare Conference

PR Newswire April 10, 2015